Capital Bank & Trust’s Integra LifeSciences IART Stock Holding History

Capital Bank & Trust’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-517	Closed	-$30K	–	731
2019 Q4	$30K	Sell	517 -216,590	-100%	-$12.9M	﹤0.01%	492
2019 Q3	$13M	Sell	217,107 -2,457	-1%	-$146K	0.18%	102
2019 Q2	$12.3M	Buy	219,564 +1,866	+0.9%	+$96.1K	0.15%	109
2019 Q1	$12.1M	Buy	217,698 +18,519	+9%	+$943K	0.15%	109
2018 Q4	$8.98M	Sell	199,179 -19,704	-9%	-$1.08M	0.13%	112
2018 Q3	$14.4M	Sell	218,883 -2,952	-1%	-$183K	0.18%	108
2018 Q2	$14.3M	Buy	221,835 +7,400	+3%	+$458K	0.19%	108
2018 Q1	$11.9M	Buy	+214,435	New	+$11.2M	0.16%	115

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Capital Bank & Trust's IART Position: Q1 2020 in Review

Capital Bank & Trust sold out of Integra LifeSciences (IART) in Q1 2020, closing a stake of 517 shares — an estimated $30K sold.

Capital Bank & Trust first reported a position in IART in Q1 2018 and held it in 8 quarters. The position peaked at $14.4M in Q3 2018. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

Capital Bank & Trust reported no remaining Integra LifeSciences position as of Q1 2020 after selling out during the quarter.
Capital Bank & Trust sold 517 Integra LifeSciences shares in Q1 2020, an estimated $30K.
Capital Bank & Trust first reported a position in Integra LifeSciences in Q1 2018 and held it in 8 quarters.
Capital Bank & Trust's Integra LifeSciences position peaked at $14.4M in Q3 2018.
258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Capital Bank & Trust's 13F filing for Q1 2020, filed 15 May 2020.